How long does it take in any individual patients to show prevention or a mediation after cancer treatment. How many patients would be needed to show affect. How much is that other company that Patrick Cox recommended spending four 100 patients in Spain for a phase 2B that could conceivably lead to accelerated approval. I believe they’re doing that trial for something like $5 million in Spain. How likely is Exceller rated approval for a drug that is only switched and spit and us is very likely to be extremely safe and meets a critical unmet need. My humble answer based on what’s going on with that other company is $5 million and nine months seems to me this is doable without a partner but I’m betting there’s a European partner that will have geography limited to Europe. Could the clinics already be being lined up?
Market Data 
Markets 
AI
